Literature DB >> 1874721

Isoform diversity of phosphorylase kinase alpha and beta subunits generated by alternative RNA splicing.

B Harmann1, N F Zander, M W Kilimann.   

Abstract

We have sequenced rabbit cDNAs that encode one isoform of the alpha subunit and two isoforms of the beta subunit of phosphorylase kinase, in addition to the single isoform from fast skeletal muscle that has been characterized to date for each subunit. All these isoforms are generated by alternative RNA splicing. The alpha subunit sequence obtained from slow skeletal muscle (soleus) is characterized by an internal deletion of 59 amino acids. This deletion is predominant in mRNA from slow muscle, heart, and uterus and accounts for the smaller alpha subunit variant (alpha') characteristic of phosphorylase kinase purified from slow muscle and heart. The beta subunit mRNA can be differentially spliced at two sites. In all tissues (except skeletal muscle) that were analyzed, an internal segment encoding 28 amino acids of the muscle sequence is replaced by a homologous sequence of identical length, presumably through the use of mutually exclusive exons. In brain and some other tissues, the deduced N-terminal sequence of the beta subunit is also changed. This is achieved by an insertion into the mRNA sequence that interrupts the initial reading frame after 25 codons and starts a new reading frame, encoding a different N terminus of 18 amino acids. This modification probably affects the major regulatory phosphorylation site of the beta subunit.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1874721

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  cDNA cloning of a liver isoform of the phosphorylase kinase alpha subunit and mapping of the gene to Xp22.2-p22.1, the region of human X-linked liver glycogenosis.

Authors:  J J Davidson; T Ozçelik; C Hamacher; P J Willems; U Francke; M W Kilimann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

2.  Autosomal recessive phosphorylase kinase deficiency in liver, caused by mutations in the gene encoding the beta subunit (PHKB).

Authors:  I E van den Berg; E A van Beurden; J B de Klerk; O P van Diggelen; H E Malingré; M M Boer; R Berger
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

Review 3.  Genetic deficiencies of the glycogen phosphorylase system.

Authors:  J Hendrickx; P J Willems
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

4.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

Review 5.  Specific features of glycogen metabolism in the liver.

Authors:  M Bollen; S Keppens; W Stalmans
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

Review 6.  The regulation of glycogenolysis in the brain.

Authors:  Owen W Nadeau; Joseph D Fontes; Gerald M Carlson
Journal:  J Biol Chem       Date:  2018-02-26       Impact factor: 5.157

7.  Interaction sites on phosphorylase kinase for calmodulin.

Authors:  L M Heilmeyer; A M Gerschinski; H E Meyer; H P Jennissen
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

8.  The structure of the large regulatory α subunit of phosphorylase kinase examined by modeling and hydrogen-deuterium exchange.

Authors:  Mary Ashley Rimmer; Owen W Nadeau; Jianyi Yang; Antonio Artigues; Yang Zhang; Gerald M Carlson
Journal:  Protein Sci       Date:  2017-11-21       Impact factor: 6.725

9.  X-linked liver phosphorylase kinase deficiency is associated with mutations in the human liver phosphorylase kinase alpha subunit.

Authors:  I E van den Berg; E A van Beurden; H E Malingré; H K van Amstel; B T Poll-The; J A Smeitink; W H Lamers; R Berger
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

10.  Human cDNA encoding the muscle isoform of the phosphorylase kinase gamma subunit (PHKG1).

Authors:  M Wehner; M W Kilimann
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.